HUMAN PAPILLOMAVIRUS (HPV): CURRENT STRATEGIES FOR THE PREVENTION AND TREATMENT OF PRECANCEROUS LESIONS
Open Access
- 28 August 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Abstract
Background: Human papillomavirus (HPV) infection is the primary etiology of cervical cancer and its immediate precursors, collectively known as cervical intraepithelial neoplasia (CIN). Although primary prevention via prophylactic vaccination and secondary screening have significantly reduced incidence, cervical cancer remains a major global health burden, particularly in low- and middle-income countries. This comprehensive review evaluates the current landscape of HPV virology, pathogenesis, advanced diagnostic risk-stratification biomarkers, and evolving management paradigms. Methods: This review synthesizes current literature regarding high-risk HPV types (predominantly HPV16 and 18), viral oncogene mechanisms (E6 and E7), multi-modal screening protocols, and therapeutic interventions ranging from standard surgical excisions to novel non-invasive modalities. Results: While large loop excision of the transformation zone (LLETZ) remains the gold standard for high-grade CIN, its associated obstetric complications necessitate fertility-sparing alternatives. Recent advances highlight the efficacy of non-invasive modalities—including thermal ablation, photodynamic therapy (PDT), and topical immunomodulators such as imiquimod—which achieve high rates of lesion regression and viral clearance while preserving cervical structural integrity. Furthermore, diagnostic precision has been markedly improved through the integration of molecular markers (p16/Ki-67, DNA methylation signatures, and circulating microRNAs) and emerging microbiome-targeted adjunctive therapies. Conclusions: The management of HPV-associated precancerous lesions is shifting from standardized surgical excision to a personalized, molecularly guided, and fertility-preserving paradigm. Future clinical efforts must focus on expanding global vaccine access while implementing multi-modal, minimally invasive therapeutic strategies.Keywords
This publication has 54 references indexed in Scilit:
- First proctological application of a noncontact nitrous oxide cryotherapy device treating nonmalignant intra- and perianal HPV-related lesionsTechniques in Coloproctology, 2026
- Mobile health strategies to improve HPV vaccination uptake among parents of adolescent girls: a scoping reviewVaccine, 2026
- Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment servicesMolecular Aspects of Medicine, 2025
- Evaluation of the efficacy of carbon dioxide laser combined with 5-aminolevulinic acid photodynamic therapy in treating high-grade vaginal squamous intraepithelial lesions following hysterectomyPhotodiagnosis and Photodynamic Therapy, 2025
- Evaluation of topical photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) for cervical intraepithelial neoplasia with human papillomavirus (HPV) infection: a retrospective comparative study versus loop electrosurgical excision procedure (LEEP)Photodiagnosis and Photodynamic Therapy, 2025
- Single‐cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesionsCancer Communications, 2023
- Sexually Transmitted Human PapillomavirusInfectious Disease Clinics of North America, 2023
- Test of cure and beyond: superiority of thermal ablation over LLETZ in the treatment of high-grade CINArchives of Gynecology and Obstetrics, 2022
- 4553 An investigation into the use of curcumin, a topical herbal agent, for the treatment of cervical intraepithelial neoplasiaJournal of Clinical and Translational Science, 2020
- Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for preventionCancer Medicine, 2019